Clinical trial · Observational
The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients
The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients: a Prospective Observational Cohort Study
NCT03290001CI-TRIAL-00030242unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective, observational cohort study aimed to explore the influence of anxiety and depression to long term survival in nasopharyngeal carcinoma patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Progress-free survival
- timeFrame
- 3 years
- description
- Progress-free survival is calculated from the date of registration to the date of the first progress at any site.
Secondary outcomes (7)
- measure
- Anxiety related measure
- timeFrame
- Baseline, completion of radiation therapy (up to 12 weeks)
- description
- Hospital Anxiety and Depression Scale (HADS) and Hamilton Anxiety Rating Scale (HAMA) will be used during the assessment.
- measure
- Distress related measure
- timeFrame
- Baseline, completion of radiation therapy (up to 12 weeks)
- description
- Hospital Anxiety and Depression Scale (HADS) and Hamilton Depression Rating Scale (HAMD) will be used during the assessment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma, including WHO II or III * Age between 18-70 * Male and no pregnant female * Patient have signed on the informed consent, and well understood the objective and procedure of this study Exclusion Criteria: * The presence of uncontrolled life-threatening illness * Pregnancy or lactation * Patient with severe medical condition
References
Publications (0)
Data not yet available
No reference posted for this study.